INDIANAPOLIS, Nov. 9, 2024 /PRNewswire/ -- More than 16,000 participants took on downtown Indianapolis this morning in the 17 th annual CNO Financial Indianapolis Monumental Marathon, Half Marathon ...
November 8, 2024) - Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Metagenomi Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX) on behalf of ...
Peak Minerals also announces the creation of an Advisory Board to assist its Suriname initiative. John Williamson, founder of Metals Group, and Mario Stifano, CEO of Galantas Gold have agreed to join.
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Xerox Holdings Corporation ("Xerox" or the "Company") (NASDAQ:XRX). Such investors are ...
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of MGP Ingredients, Inc. ("MGP" or the "Company") (NASDAQ:MGPI). Such investors are advised ...
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of CECO Environmental Corp. ("CECO" or the "Company") (NASDAQ:CECO). Such investors are ...
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Laser Photonics Corp. ("Laser Photonics" or the "Company") (NASDAQ:LASE). Such investors ...
INTEGRA RESOURCES COMPLETES TRANSACTION WITH FLORIDA CANYON GOLD, CREATING A NEW GREAT BASIN PRECIOUS METALS PRODUCER ...
NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Service Properties Trust ("SVC" or the "Company") (NASDAQ:SVC). Such investors are ...
You have until November 29, 2024, to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired Paragon 28 securities during the Class ...
Then, on May 1, 2024, Metagenomi announced that it and Moderna, Inc. had "mutually agreed to terminate their collaboration on primary hyperoxaluria type 1 (PH1)," and that the "rights to develop the ...